How long does it take for gilitinib to take effect?
Gilitinib is a targeted therapy drug used to treat FLT3 mutation-positive acute myeloid leukemia (AML). Its mechanism of action is mainly to achieve therapeutic effect by inhibiting the activity of FLT3 receptor kinase and blocking the proliferation and survival of leukemia cells. The time it takes for giritinib to work varies from person to person, but it usually starts to show some benefit within a few weeks of starting treatment.
1.Rapid reduction in the number of leukemia cells: Some patients will see a rapid reduction in the number of leukemia cells after starting giritinib treatment. During the early stages of treatment with giritinib, some patients may observe a decrease in leukemia cell numbers, improvement in symptoms, and changes in bone marrow pathology.

2.Improvement of symptoms: Treatment with giritinib is usually accompanied by improvement of symptoms. For example, patients may experience a reduction in symptoms such as fatigue, anemia, and infections, as well as an increase in appetite.
3.Continuous treatment: Although gilitinib may show some efficacy within a few weeks of starting treatment, it usually needs to be continued for a period of time to achieve optimal treatment effects. Therefore, patients need to continue taking medication as directed by their doctor and undergo regular clinical evaluation and monitoring.
4.It should be noted that the efficacy and response time of giritinib will vary depending on the severity of the patient's disease, individual differences and other factors. Therefore, it is necessary to pay close attention to changes in the patient's condition during the treatment process and adjust the treatment plan in a timely manner. During treatment, patients should undergo regular blood tests and clinical evaluations to monitor treatment effects, and promptly report any discomfort or abnormal symptoms to their doctor.
In general, giritinib generally shows some efficacy within a few weeks of starting treatment, but continued treatment and regular monitoring are key to ensuring optimal treatment results.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)